Leading the way for over 30 years
Throughout our history as an innovator in autoimmune diagnostics, we’ve been driven by a simple mission: help labs improve the way patients with autoimmune diseases are diagnosed, monitored, and treated. Since 1987, we’ve continually worked with clinical researchers to develop new biomarkers for more accurate testing. We also collaborate with experts in automation to deliver more efficient systems that help clinical labs improve their testing processes.
Werfen values
With these core pillars at the center of our shared values within Werfen, we also strive to nurture the following qualities in all of our team members.
Leadership and management
Teamwork Meets Innovation
We are dedicated to solid leadership and collaborative teamwork that allows us to carry out the strategy and the mission of our company in a purposeful way. We continue to invest in innovation, as it is the catalyst for the growth and success of our business and the key to our competitive advantage.
Integrity
Honesty, Humility, and Respect for People
We always live up to our words. We say what we mean and we mean what we say. We are direct and straightforward and we deliver according to the expectations we have generated, allowing us to build trust and credibility among our customers and stakeholders.
FEATURED NEWS
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is proud to announce the clearance of QUANTA Flash® Calprotectin by the US Food and Drug Administration (FDA). QUANTA Flash Calprotectin aids in the diagnosis of inflammatory bowel disease (IBD) and helps differentiate IBD from irritable bowel syndrome (IBS). QUANTA Flash Calprotectin is one of 29 FDA cleared assays available on BIO-FLASH®, a random access chemiluminescent instrument, and can be run simultaneously with other QUANTA Flash assays. QUANTA Flash Calprotectin is the first fully automated, random access calprotectin assay available in the US.
OUR LATEST INNOVATIONS
QUANTA-Lyser 3000
QUANTA-Lyser 3000 is a high throughput EIA/IFA that give you the ability to complete your workload faster with less hands-on time. That equates to maximum efficiency with increased productivity, all while safeguarding reagent and patient traceability to ensure integrity of results.
CAREERS
It All Starts With People
Our talent is, without question, our most important asset. Our employees are the face of Inova, and they represent our values in their day-today interactions.
NEWS & EVENTS
Stay on top of it all.
Check out our latest news and events in autoimmune diagnostics from all over the world.
December 21, 2017
Inova Diagnostics Launches Next Generation EIA/IFA Processor
March 14, 2017
New Random Access Chemiluminescent Assay for Inflammatory Bowel Disease Launched
July 29, 2018 - August 02, 2018
American Association for Clinical Chemistry (AACC)
August 01, 2018 - August 01, 2018
AACC Breakfast Workshop
August 17, 2018 - August 19, 2018
Association of Medical Laboratory Immunologists (AMLI)
Contact us
Please contact us directly via email, telephone, or with the following form.
EMAIL:
support@inovadx.com
TOLL FREE PHONE:
800.545.9495
PHONE:
858.586.9900
FAX:
858.586.9911
